The intrinsic fluorescence of hunman erythrocyte membranes excited by unpolarized and polarized light has been studied with and without the addition of human growth hormone. The peak emission intensity of the membranes appeared at 332 nm, with a distinct shoulder at about 303 nm. Excitation spectra contained two peaks, at 282 and 225 nm. Fluorescence polarization was maximal (about 0.4) The data are consistent with the proposition that human growth hormone, by some cooperative mechanism, produces a conformational change in the membrane proteins with associated depolarization of fluorescence.
A change was noted in the far-ultraviolet circular dichroism (CD) spectrum of human erythrocyte membranes in the presence of human growth hormone (HGH), but not of bovine hormone (BGH) (1) . In addition, the near-ultraviolet CD spectrum of HGH was altered by human erythrocyte membranes (1) , suggesting a change in the conformation of the hormone. It was considered likely that the changes in optical activity of the membranes were not the result of distortions or artifacts of particulate (or membrane) systems (2-6), since no changes in light scattering or phase-contrastmicroscopic appearance of the membranes were noted (1) . This suggested that the decreased optical activity was the consequence of conformational changes in membrane proteins upon interaction with HGH. In order to obtain more data about possible conformational changes of membrane proteins, the interaction of erythrocyte membranes and HGH has been studied by fluorescence and polarization of intrinsic fluorescence.
MATERIALS AND METHODS
Sterile solutions were used to prepare erythrocyte membranes from freshly drawn human blood by methods detailed by Dodge et al. (7), Marchesi et al. (8) , or Steck et al. (9) . Stock suspensions of these membrane preparations were maintained at 4°C and were used as long as they were responsive to HGH. Protein concentrations of the membrane preparations were determined from the A2m of 2-chloroethanol solutions prepared from measured amounts of the original membrane suspension (10) . Membranes were counted under a phasecontrast microscope in a Petroff-Hauser counter. HGH was prepared from human pituitaries obtained at autopsies by the method of Saxena and Henneman (11), and contained one major and two minor bands by polyacrylamide disc electrophoresis. BGH was prepared in this laboratory by a modification (12) of the method of Dellacha and Sonenberg (13) , and was homogeneous by polyacrylamide disc electrophoresis. The biologically active fragment (A-II) obtained from a tryptic digest of BGH was prepared by the method of Yamasaki et al. (14) . [This A-II fragment of molecular weight 5000 and 37 amino acids was homogeneous by polyacrylamide disc electrophoresis, gel filtration, and sedimentation equilibrium (14) .] All other reagents were of analytic grade.
Fluorescence measurements were made on a Cary 50-026-900 differential spectrophotofluorometer employing frontsurface illumination, where the exciting and emitting beams subtend an angle of 230. The illuminating source consists of a 450-W, short-arc xenon lamp, powered by a variable DC supply capable of delivering from 0 to 25 A. This instrument is equipped with a Rhodamine B quantum detector located within the sample compartment. The quantum detector optical signal is directed by a fiber-optic light pipe through a filter onto the phototube cathode. This is the same phototube that views sample signals. The signals from the phototube amplifier are directed to the measurement system. The recorder displays the ratio of the sample signal or the ratio of the difference between sample signals to the quantum detector signal. Thus, fluorescence intensity has been corrected for fluctuations in illumination intensity. Excitation spectra have been corrected for variations in light intensity with wavelength, monochromator transmission, and photomultiplier response. For polarization studies, a crystal polarizer is inserted directly in front of the sample and a sheet polarizer is inserted between the sample and collecting optics. The water-jacketed cell compartment is connected to a thermostatted water bath for precise temperature control.
Duplicate spectra were obtained for each sample during a 20-to 30-min period. (Suspensions were stable, as shown by replicate spectra, over an 8-hr period.) For emission spectra, samples were excited at 275, 280, 295, and 303 nm. All spectra have been corrected instrumentally and are presented as obtained on the recorder. No inner-filter corrections were reAbbreviations: HGH, human growth hormone; BGH, bovine growth hormone. quired, inasmuch as the fluorescence intensity was linearly related to suspension concentration over the range employed in these experiments. No corrections for Rayleigh or Raman light scattering were found necessary at the concentrations and instrumental settings used in these experiments. Fluorescence intensity is presented on an arbitrary scale. Differences considered significant are only those that exceeded instrumental noise and any differences with control procedures (e.g., solvent addition, mixing of cuvette contents, etc.). The combined instrumental and experimental error was generally 2% or less.
Polarization of fluorescence, as used herein, refers to the ratio, (In-II/Jil + I1) of the fluorescence intensities of the components with electric vectors oriented in mutually perpendicular directions, and In is the component whose electric vector is parallel to that of the exciting radiation.
RESULTS With excitation at 275 nm, the emission spectrum ( Fig. 1 ) of a human erythrocyte membrane suspension in KrebsRinger bicarbonate buffer (pH 7.4) at 370C was asymmetric, with a peak emission at 332 nm and a shoulder at 303 nm ( Fig. 1 ). The peak intensity at 332 nm was generally about three times as intense as the shoulder at 303 nm. Addition of HGH ( Fig. 1) , at a final concentration of 1 X 10-16 M, resulted in a 15-20% decrease in fluorescence at 332 and 303 nm. Concentrations below 1 X 10-1r M were without effect. The quenching of fluorescence became apparent as soon as measurements could be made (within 1 min) after the addition of HGH; no additional decrease in fluorescence was noted at longer times or after further addition of HGH to concentrations of 5 X 10-12, 5 X 10-9, and 5 X 10-6 M. No fluorescence of HGH was apparent at concentrations below 5 X 10-6 M, under the same conditions in the absence of the membranes, at the instrument settings employed in these experiments. Excitation at 295 nm led to an emission spectrum with the major peak at 332 nm as previously noted (Fig.  1 ). However, it was not possible from such spectra to assign reliable values to the shoulder at 303 nm. In addition, HGH did not modify the spectra produced by excitation at 295 nm.
BGH or bovine serum albumin, when added to membranes at concentrations (1 X 10-15 M to 5 X 10-9 M) similar to those used with HGH, did not cause the decrease in fluorescence (Fig. 2 ). In addition, no effect on the membrane fluorescence was noted with the addition of equivalent volumes of dilute (7 mM) phosphate buffer, 0.16 M NaCl, or water. Membrane preparations obtained from several donors, and from blood treated with anticoagulants (heparin, acid citrate dextrose, or EDTA) were equally responsive to the quenching effect of HGH. No significant differences were noted in the responsiveness to HGH of the membranes prepared by any of the three methods noted above (6) (7) (8) . Membranes did not respond to HGH at pH 6.0 or 8.0 (phosphate buffer), as opposed to the quenching response at pH 7.4. Additionally, membranes that had been frozen and thawed 4 times at pH 7.4 demonstrated no decrease in fluorescence upon the addition of HGH.
Although dilute (7 mM) phosphate buffer, pH 7.4, served as an adequate solvent for the study of membrane fluorescence in the presence and absence of HGH, Krebs-Ringer bicarbonate buffer, pH 7.4, appeared to be more desirable in terms of the greater quenching (16% vs. 10%) with HGH. In KrebsRinger phosphate buffer, pH 7.4, as well as in isotonic saline, there was a similar emission spectrum of the membranes, but the fluorescence was not quenched with HGH. This negative result was duplicated with each solvent with membrane preparations whose fluorescence was quenched in Krebs-Ringer bicarbonate buffer.
With excitation at 275 nm, HGH decreased the intensity of the emission peak at 332 nm not only with unpolarized light (Fig. 1) , but with polarized light as well. Thus, in six experiments, HGH produced a decrease in the polarization of fluorescence at 332 nm of the membranes from 0.336 (0.306-0.396) to 0.253 (0.150-0.330). As with unpolaiized light (Fig. 1) , there was no apparent shift in the emission peak due to HGH.
With emission set at 332 nm, an excitation spectrum was obtained (Fig. 3) of the membranes alone, and in the presence of 1 X 10-15 M HGH. Although the fluorescence of the membranes in the presence of HGH decreased at all exciting wave lengths, the greatest decreases (of about 19%) were noted at the major excitation peaks at 225 and 282 nm, with little change at excitation of 295 nm. This result was consistent with the emission spectrum obtained with excitation at 295 nm, where no effect of HGH on the membrane fluorescence was noted.
An average plot (Fig. 4) of three excitation polarization spectra of erythrocyte membranes reveals a gradual decline from a high polarization of 0.396 at 295 nm to a low of 0.137 at 220 nm. There appear to be shoulders in these curves between 282 and 260 nm, as well as between 240 and 220 nm. In the presence of HGH the polarization ratios were generally lower except in the region between 250 and 265 nm.
When the biologically active peptide (A-II) derived from a tryptic digest of bovine growth hormone (14) was added to the membranes, which were excited at 275 nm with unpolarized light, there was a decrease in fluorescence intensity (Fig.  5 ). This decrease in fluorescence intensity at 332 nm was more apparent at the excitation peak of 282 nm, as revealed in the excitation spectrum with unpolarized light (Fig. 6) . From the fluorescence excitation spectrum (Fig. 6) , it is apparent that A-II peptide decreased the fluorescence intensity at both 225 and 282 nm.
DISCUSSION
These experiments suggest that intrinsic fluorescence is a valid technique for studying erythrocyte membrane structure, and the effect of perturbants such as growth hormone on such structure. The membrane suspensions were sufficiently stable in the solvents used in this study to Despite the fact that human erythrocyte membranes contain several proteins of different molecular weights (15, 16) , some generalizations can be made about the intrinsic fluorescence spectra of the membranes. Tryptophan is probably the source of the 332 nm peak (Fig. 1) , which appears at shorter wavelength due to its apolar environment in either membrane protein or lipid. Similarly, the distinct shoulder at 303 nm originates from tyrosine residues in a more aqueous environment, possibly on the membrane surface. It is significant that excitation at 295 nm with a sufficiently narrow excitation slitwidth gave an emission spectrum, with peak intensity at 332, without the 303 nm shoulder. Thus, only tryptophan would appear to be excited by excitation at 295 nm, while both tyrosine and tryptophan may have been excited at 282 nm. Some tryptophan excitation may be the consequence of energy transfer from the fluorescence of tyrosine, whose broad emission peak significantly overlaps the absorption band of tryptophan. In a previous study (17) , excitation of human erythrocyte membranes at 270, 286, or 290 nm revealed "no evidence of tyrosine fluorescence at 310 nm". It was concluded (17) that this "indicates a transfer of excitation energy from tyrosine to tryptophan". An excitation spectrum of erythrocyte membranes revealed a main excitation band, with a corrected maximum at 275 nm, and another band, with an uncorrected maximum at 235 nm (17) . In the present study, an excitation spectrum of the membranes alone in several buffers consistently revealed (Fig. 3) two bands, with corrected maxima at 282 and 225 nm. Whether the difference noted between the two studies represents differences in the spectrofluorometers, experimental conditions, or both is not clear. Although there are absorption peaks for the peptide bond, tyrosine, and tryptophan in the region of 225 nm, the fluorescence is most likely to originate from tryptophan, either directly or indirectly, by energy transfer from tyrosine.
HGH, in concentrations as low as 1 X 10-16 M [70 molecules of hormone/membrane or 70 molecules per 1.45 X 10-6 cm2 (18) ] was effective in decreasing the intrinsic fluorescence intensity of human erythrocyte membranes at the emission peak of 332 nm. No shift in the position of the peak was observed. The hormonal specificity of this interaction is attested to by the lack of response of human erythrocyte membranes to BGH, a hormone without effect on human tissues. However, a peptide (14) derived from a tryptic digest of bovine growth hormone, which is metabolically active in hypopituitary humans (unpublished observations), was as effective as HGH in decreasing the intensity of membrane fluorescence. No effect on membrane fluorescence was noted with the addition of various diluents (water, 7 mM phosphate solution, or isotonic saline). At the concentration of HGH used, there was no contribution of intrinsic hormone fluorescence. The hormonal effect on fluorescence is very likely physiologically meaningful, since it was demonstrable only with intact membranes at 370C and pH 7.4, but not at pH 6.0 or 8.0.
HGH has been reported (19) (20) (21) (22) to inhibit glucose consumption by intact human erythrocytes in vitro. More specifically, HGH decreased lactic acid production and enhanced the accumulation of glucose-6-phosphate and fructose-6-phosphate due to an inhibition of phosphofructokinase; it also increased pyruvate production, with a decrease in pyruvate kinase and an increase in lactic dehydrogenase activity (21, 22) . HGH also depressed ATP production, to a greater extent in Krebs-Ringer bicarbonate buffer than in phosphate buffer (21) . In this study, the quenching effect of HGH on the fluorescence of human erythrocyte membranes was also more apparent in Krebs-Ringer bicarbonate buffer. That the response was not demonstrable with Krebs-Ringer phosphate buffer, and was present in dilute phosphate buffer alone, may well be related to the different phosphate concentrations (i.e., 154 mM and 7 mM, respectively). Although the fluorescence of the membranes, which presumably originated in tryptophan residues, remained, tyrosine fluorescence was not noted in Krebs-Ringer phosphate buffer. Phosphate has been reported (23) to quench tyrosine, but not tryptophan, fluorescence in human serum albumin.
The decrease in fluorescence of human erythrocyte membranes caused by HGH was demonstrable with membranes from several donors, prepared by several methods, from blood that was treated with three different anticoagulants. The effects was dependent on some degree of membrane organization, since freezing and thawing, a procedure known to disrupt membianes, destroyed the ability of the membranes to respond to HGH.
The effect of HGH on human erythrocyte membranes was only apparent at wavelengths where there was some degree of excitation of tyrosine residues (275 or 280 nm), and not at wavelengths where excitation was predominantly of tryptophan residues (295 nm). It seems likely that there was energy transfer from excited tyrosine residues to tryptophan, and that the quenching of fluorescence by HGH was predominantly an effect on tyrosine (see above). It may be that this "quenching" was the consequence of a conformational change in a membrane protein(s) in which some tyrosine residues were brought close to another constituent e.g. -CONH or -COOH groups (24) (25) (26) (27) , resulting in some quenching of fluorescence. It is not likely that HGH itself was the quencher since at the concentrations employed in these experiments there is about 106 times more membrane tryptophan (15) present than HGH, and the induced conformational change appears to be of a cooperative (28, 29) nature.
The high degree of polarization of fluorescence (e.g. about 0.3 with excitation at 280 nm and emission at 332 nm) suggests a rigid environment of the fluorophores, consistent with the formulations derived from other experimental approaches (30) . A decrease in polarization from 0.336 to 0.253 under the influence of HGH suggests either a decreased relaxation time or a conformational change with quenching of fluorescence. Although HGH might, in some way, alter the viscosity of the membranes with a subsequent decrease in relaxation time, a change in the conformation of membrane protein is consistent with earlier observations (1) of a conformational change; at present this latter explanation seems more likely.
